Insider · CIK 0001913245

Danahy Kevin Patrick

Reports to the SEC for 1 company · HAYWARD, CA

sec.gov

Transactions

Companies

Filings

CIK

0001913245

Forms 4 and 5

Insider transactions

45 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-18	PLSEPULSE BIOSCIENCES, INC.S Sale	Chief Commercial Officer	SSale	−5,000 sh	$23.64	−$118K	43,298
2026-02-18	PLSEPULSE BIOSCIENCES, INC.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+5,000 sh	$1.53	+$7,650	48,298
2026-02-18	PLSEPULSE BIOSCIENCES, INC. · Stock Option (right to buy)M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−5,000 sh	—	—	300,000
2026-02-17	PLSEPULSE BIOSCIENCES, INC.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+20K sh	$1.53	+$30.6K	63,298
2026-02-17	PLSEPULSE BIOSCIENCES, INC.S Sale	Chief Commercial Officer	SSale	−20K sh	$23.63	−$473K	43,298
2026-02-17	PLSEPULSE BIOSCIENCES, INC. · Stock Option (right to buy)M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−20K sh	—	—	305,000
2026-02-13	PLSEPULSE BIOSCIENCES, INC.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+20K sh	$1.53	+$30.6K	63,298
2026-02-13	PLSEPULSE BIOSCIENCES, INC. · Stock Option (right to buy)M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−20K sh	—	—	325,000
2026-02-13	PLSEPULSE BIOSCIENCES, INC.S Sale	Chief Commercial Officer	SSale	−20K sh	$23.53	−$471K	43,298
2026-02-12	PLSEPULSE BIOSCIENCES, INC.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+20K sh	$1.53	+$30.6K	63,298
2026-02-12	PLSEPULSE BIOSCIENCES, INC.S Sale	Chief Commercial Officer	SSale	−20K sh	$23.37	−$467K	43,298
2026-02-12	PLSEPULSE BIOSCIENCES, INC. · Stock Option (right to buy)M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−20K sh	—	—	345,000
2026-02-11	PLSEPULSE BIOSCIENCES, INC.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+20K sh	$1.53	+$30.6K	63,298
2026-02-11	PLSEPULSE BIOSCIENCES, INC. · Stock Option (right to buy)M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−20K sh	—	—	365,000
2026-02-11	PLSEPULSE BIOSCIENCES, INC.S Sale	Chief Commercial Officer	SSale	−20K sh	$25.20	−$504K	43,298
2026-02-10	PLSEPULSE BIOSCIENCES, INC.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+20K sh	$1.53	+$30.6K	63,298
2026-02-10	PLSEPULSE BIOSCIENCES, INC.S Sale	Chief Commercial Officer	SSale	−20K sh	$23.52	−$470K	43,298
2026-02-10	PLSEPULSE BIOSCIENCES, INC. · Stock Option (right to buy)M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−20K sh	—	—	385,000
2026-02-09	PLSEPULSE BIOSCIENCES, INC. · Stock Option (right to buy)M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−20K sh	—	—	405,000
2026-02-09	PLSEPULSE BIOSCIENCES, INC.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+20K sh	$1.53	+$30.6K	63,298
2026-02-09	PLSEPULSE BIOSCIENCES, INC.S Sale	Chief Commercial Officer	SSale	−20K sh	$21.45	−$429K	43,298
2025-10-02	PLSEPULSE BIOSCIENCES, INC.S Sale	Chief Commercial Officer	SSale	−4,600 sh	$18.53	−$85.2K	43,298
2025-10-02	PLSEPULSE BIOSCIENCES, INC.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+4,600 sh	$1.53	+$7,038	47,898
2025-10-02	PLSEPULSE BIOSCIENCES, INC. · Stock Option (right to buy)M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−4,600 sh	—	—	425,000
2025-09-19	PLSEPULSE BIOSCIENCES, INC. · Stock Option (right to buy)M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−400 sh	—	—	429,600
2025-09-19	PLSEPULSE BIOSCIENCES, INC.S Sale	Chief Commercial Officer	SSale	−400 sh	$18.48	−$7,392	43,298
2025-09-19	PLSEPULSE BIOSCIENCES, INC.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+400 sh	$1.53	+$612	43,698
2025-09-18	PLSEPULSE BIOSCIENCES, INC.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+20K sh	$1.53	+$30.6K	63,298
2025-09-18	PLSEPULSE BIOSCIENCES, INC. · Stock Option (right to buy)M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−20K sh	—	—	430,000
2025-09-18	PLSEPULSE BIOSCIENCES, INC.S Sale	Chief Commercial Officer	SSale	−20K sh	$18.49	−$370K	43,298
2024-07-03	PLSEPULSE BIOSCIENCES, INC.X Exercise of In-Money	Chief Commercial Officer	XExercise of In-Money	+650 sh	—	—	36,537
2024-07-03	PLSEPULSE BIOSCIENCES, INC. · Warrant (right to buy)P Purchase	Chief Commercial Officer	PPurchase	+325 sh	—	—	325
2024-07-03	PLSEPULSE BIOSCIENCES, INC. · Warrant (right to buy)P Purchase	Chief Commercial Officer	PPurchase	+325 sh	—	—	325
2023-11-16	PLSEPULSE BIOSCIENCES, INC.P Purchase	Chief Commercial Officer	PPurchase	+600 sh	$6.51	+$3,906	35,875
2023-11-16	PLSEPULSE BIOSCIENCES, INC.P Purchase	Chief Commercial Officer	PPurchase	+4,781 sh	$6.52	+$31.2K	35,275
2023-11-16	PLSEPULSE BIOSCIENCES, INC.P Purchase	Chief Commercial Officer	PPurchase	+12 sh	$6.50	+$78	35,887
2023-11-01	PLSEPULSE BIOSCIENCES, INC. · Stock Option (right to buy)A Award	Chief Commercial Officer	AAward	+460K sh	—	—	460,000
2023-11-01	PLSEPULSE BIOSCIENCES, INC. · Stock Option (right to buy)J Other	Chief Commercial Officer	JOther	−130K sh	—	—	0
2023-10-23	PLSEPULSE BIOSCIENCES, INC. · Stock Option (right to buy)A Award	Chief Commercial Officer	AAward	+130K sh	—	—	130,000
2023-07-12	PLSEPULSE BIOSCIENCES, INC. · Stock Option (right to buy)A Award	Chief Commercial Officer	AAward	+200K sh	—	—	200,000
2023-04-29	PLSEPULSE BIOSCIENCES, INC. · Stock Option (right to buy)A Award	Chief Commercial Officer	AAward	+500K sh	—	—	500,000
2023-03-17	PLSEPULSE BIOSCIENCES, INC. · Stock Option (right to buy)A Award	Chief Commercial Officer	AAward	+25K sh	—	—	25,000
2022-09-30	PLSEPULSE BIOSCIENCES, INC.P Purchase	Chief Commercial Officer	PPurchase	+6,500 sh	$2.30	+$14.9K	6,500
2022-09-23	PLSEPULSE BIOSCIENCES, INC. · Stock Option (right to buy)A Award	Chief Commercial Officer	AAward	+450K sh	—	—	450,000
2022-02-14	PLSEPULSE BIOSCIENCES, INC. · Stock Option (right to buy)A Award	Chief Commercial Officer	AAward	+300K sh	—	—	300,000

Recent filings

Accepted (ET)
Feb 234
Danahy Kevin Patrick0001437749-26-005144
SEC(opens sec.gov)
Feb 174
Danahy Kevin Patrick0001437749-26-004438
SEC(opens sec.gov)
Feb 114
Danahy Kevin Patrick0001437749-26-003840
SEC(opens sec.gov)

Companies

PULSE BIOSCIENCES, INC.Chief Commercial OfficerPLSE

Address

C/O PULSE BIOSCIENCES, INC. 3957 POINT EDEN WAY

HAYWARD, CA, 94545